• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

POLE2 可作为预后生物标志物,并与鳞状细胞肺癌的免疫浸润相关。

POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.

机构信息

Respiratory Department, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China (mainland).

School of Medicine, Nankai University, Beijing, China (mainland).

出版信息

Med Sci Monit. 2020 Apr 18;26:e921430. doi: 10.12659/MSM.921430.

DOI:10.12659/MSM.921430
PMID:32304567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7191965/
Abstract

BACKGROUND Squamous cell lung cancer is the main cause of cancer-associated mortality. The discovery of promising prognostic biomarkers for predicting the survival of patients with squamous cell lung cancer remains a challenge. MATERIAL AND METHODS Gene expression profiles of GSE33479 and GSE51855, including 42 squamous cell lung cancer tissues and 17 normal tissues, from the GEO database were assessed to find common differentially expressed genes (DEGs) via the GEO2R online tool and Venn diagram software. Then, gene ontology (GO) and Kyoto Encyclopedia of Gene and Genome (KEGG) pathway analyses were conducted. The key protein-protein interaction (PPI) network within those common DEGs was subsequently illustrated through a combination of Search Tool for Retrieval of Interacting Genes (STRING) and Cytoscape software. Finally, core genes associated with survival and levels of immune infiltration were demonstrated by the Kaplan-Meier plotter and Tumor Immune Estimation Resource (TIMER) online database, respectively. RESULTS In total, 483 DEGs were involved, including 216 upregulated genes enriched in "cell division", "DNA replication", and "DNA repair pathway" and 267 downregulated genes enriched in "cell adhesion", "oxidation-reduction process", and "cell-cell signaling". The 75 core genes were selected by Molecular Complex Detection applied in Cytoscape. Four genes - MND1, FOXM1, CDC6, and POLE2 - were found to be significantly associated with survival. Further analysis of the KEEG pathway and TIMER database revealed that only POLE2 was enriched in "DNA replication" and its higher expression was negatively associated with survival and immune infiltration. CONCLUSIONS Higher expression of POLE2 is a prognosis-related biomarker for worse survival and is negatively associated with immune infiltration in squamous cell lung cancer.

摘要

背景

鳞状细胞肺癌是癌症相关死亡的主要原因。发现有前途的预后生物标志物来预测鳞状细胞肺癌患者的生存仍然是一个挑战。

材料和方法

从 GEO 数据库中评估了 GSE33479 和 GSE51855 中包括 42 个鳞状细胞肺癌组织和 17 个正常组织的基因表达谱,通过 GEO2R 在线工具和 Venn 图软件来寻找共同差异表达基因(DEGs)。然后进行基因本体论(GO)和京都基因与基因组百科全书(KEGG)途径分析。随后,通过结合 Search Tool for Retrieval of Interacting Genes(STRING)和 Cytoscape 软件,展示了这些共同 DEGs 中的关键蛋白-蛋白相互作用(PPI)网络。最后,通过 Kaplan-Meier plotter 和 Tumor Immune Estimation Resource(TIMER)在线数据库分别显示与生存和免疫浸润水平相关的核心基因。

结果

共涉及 483 个 DEGs,其中 216 个上调基因富集在“细胞分裂”、“DNA 复制”和“DNA 修复途径”,267 个下调基因富集在“细胞黏附”、“氧化还原过程”和“细胞-细胞信号转导”。通过 Cytoscape 中的分子复合物检测,选择了 75 个核心基因。发现 4 个基因-MND1、FOXM1、CDC6 和 POLE2-与生存显著相关。进一步对 KEEG 途径和 TIMER 数据库的分析表明,只有 POLE2 富集在“DNA 复制”中,其高表达与生存和免疫浸润呈负相关。

结论

POLE2 的高表达是与预后相关的生物标志物,与鳞状细胞肺癌的生存较差和免疫浸润呈负相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/05a88c3f6a49/medscimonit-26-e921430-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/07a5ae589d83/medscimonit-26-e921430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/962a7c039d15/medscimonit-26-e921430-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/c55bd8d47f69/medscimonit-26-e921430-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/eb8b8b1a1bf9/medscimonit-26-e921430-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/4d7aac41f21e/medscimonit-26-e921430-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/05a88c3f6a49/medscimonit-26-e921430-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/07a5ae589d83/medscimonit-26-e921430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/962a7c039d15/medscimonit-26-e921430-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/c55bd8d47f69/medscimonit-26-e921430-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/eb8b8b1a1bf9/medscimonit-26-e921430-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/4d7aac41f21e/medscimonit-26-e921430-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff38/7191965/05a88c3f6a49/medscimonit-26-e921430-g006.jpg

相似文献

1
POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.POLE2 可作为预后生物标志物,并与鳞状细胞肺癌的免疫浸润相关。
Med Sci Monit. 2020 Apr 18;26:e921430. doi: 10.12659/MSM.921430.
2
Differentially Expressed Gene Screening, Biological Function Enrichment, and Correlation with Prognosis in Non-Small Cell Lung Cancer.非小细胞肺癌差异表达基因筛选、生物学功能富集及与预后的相关性分析。
Med Sci Monit. 2019 Jun 10;25:4333-4341. doi: 10.12659/MSM.916962.
3
Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.通过生物信息学分析鉴定与肝细胞癌相关的枢纽基因,CYP2C8 是一个有潜力的预后生物标志物。
Gene. 2019 May 25;698:9-18. doi: 10.1016/j.gene.2019.02.062. Epub 2019 Feb 27.
4
Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.通过生物信息学分析鉴定与 SCLC 相关的候选生物标志物和途径。
Mol Med Rep. 2018 Aug;18(2):1538-1550. doi: 10.3892/mmr.2018.9095. Epub 2018 May 29.
5
Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.通过生物信息学分析鉴定肺腺癌中具有预后价值的关键基因和潜在的肿瘤抑制因子。
BMC Cancer. 2021 May 26;21(1):616. doi: 10.1186/s12885-021-08308-3.
6
Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.与肺腺癌相关的候选诊断和预后生物标志物的综合分析。
Med Sci Monit. 2020 Jun 24;26:e922070. doi: 10.12659/MSM.922070.
7
Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.通过综合生物信息学分析鉴定和验证非小细胞肺癌中具有预后价值的关键基因。
Thorac Cancer. 2020 Apr;11(4):851-866. doi: 10.1111/1759-7714.13298. Epub 2020 Feb 14.
8
Identification for Exploring Underlying Pathogenesis and Therapy Strategy of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.基于生物信息学分析鉴定口腔鳞状细胞癌的潜在发病机制和治疗策略。
Med Sci Monit. 2019 Dec 3;25:9216-9226. doi: 10.12659/MSM.917736.
9
Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.非小细胞肺癌诊断和预后的关键生物标志物的鉴定和综合分析。
Med Sci Monit. 2019 Dec 5;25:9280-9289. doi: 10.12659/MSM.918620.
10
Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.通过生物信息学分析鉴定肾细胞癌中的关键生物标志物和潜在分子机制
J Comput Biol. 2019 Nov;26(11):1278-1295. doi: 10.1089/cmb.2019.0145. Epub 2019 Jun 24.

引用本文的文献

1
The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway.POLE2 预后枢纽基因通过 PI3K/AKT 信号通路促进膀胱癌细胞生长。
Comb Chem High Throughput Screen. 2024;27(13):1984-1998. doi: 10.2174/0113862073273633231113060429.
2
Characterization of alternative splicing events and prognostic signatures in gastric cancer.胃癌中可变剪接事件及预后特征的表征
Cancer Cell Int. 2024 May 11;24(1):167. doi: 10.1186/s12935-024-03348-8.
3
Prognostic and chemotherapeutic response prediction by proliferation essential gene signature: Investigating POLE2 in bladder cancer progression and cisplatin resistance.

本文引用的文献

1
Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.非小细胞肺癌诊断和预后的关键生物标志物的鉴定和综合分析。
Med Sci Monit. 2019 Dec 5;25:9280-9289. doi: 10.12659/MSM.918620.
2
Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.通过综合生物信息学分析筛选结直肠癌的关键基因和信号通路。
Mol Med Rep. 2019 Aug;20(2):1259-1269. doi: 10.3892/mmr.2019.10336. Epub 2019 Jun 4.
3
Prognostic significance of resident CD103CD8T cells in human colorectal cancer tissues.
通过增殖必需基因特征进行预后和化疗反应预测:探究POLE2在膀胱癌进展和顺铂耐药中的作用
J Cancer. 2024 Feb 4;15(6):1734-1749. doi: 10.7150/jca.93023. eCollection 2024.
4
POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.POLE2通过PI3K/AKT信号通路调节口腔鳞状细胞癌细胞的凋亡。
Curr Med Sci. 2023 Dec;43(6):1162-1172. doi: 10.1007/s11596-023-2813-7. Epub 2023 Dec 11.
5
MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma.MND1 作为一个潜在的预后生物标志物,与肾透明细胞癌的细胞周期和免疫浸润相关。
Aging (Albany NY). 2022 Sep 10;14(18):7416-7442. doi: 10.18632/aging.204280.
6
Induction of senescence upon loss of the Ash2l core subunit of H3K4 methyltransferase complexes.丧失 H3K4 甲基转移酶复合物的 Ash2l 核心亚基诱导衰老。
Nucleic Acids Res. 2022 Aug 12;50(14):7889-7905. doi: 10.1093/nar/gkac591.
7
Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration.肾母细胞瘤揭示 DNA 修复基因过度表达与肿瘤免疫浸润缺失有关。
J Immunother Cancer. 2022 Jun;10(6). doi: 10.1136/jitc-2022-004797.
8
Using Weighted Gene Co-Expression Network Analysis to Identify Increased MND1 Expression as a Predictor of Poor Breast Cancer Survival.使用加权基因共表达网络分析来确定MND1表达增加是乳腺癌生存不良的一个预测指标。
Int J Gen Med. 2022 May 14;15:4959-4974. doi: 10.2147/IJGM.S354826. eCollection 2022.
9
Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.通过计算机分析鉴定与头颈部鳞状细胞癌预后和免疫微环境相关的代谢重编程特征。
Cancer Med. 2022 Aug;11(16):3168-3181. doi: 10.1002/cam4.4670. Epub 2022 Mar 18.
10
Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis.利用生物信息学分析鉴定中国肺癌人群中的关键基因和生物通路。
PeerJ. 2022 Jan 31;10:e12731. doi: 10.7717/peerj.12731. eCollection 2022.
常驻 CD103CD8+T 细胞在人结直肠癌细胞组织中的预后意义。
Acta Histochem. 2019 Jul;121(5):657-663. doi: 10.1016/j.acthis.2019.05.009. Epub 2019 May 30.
4
Clinical Experience of Immunotherapy Treatment: Efficacy and Toxicity Analysis of the Compassionate Use Program of Nivolumab in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer.免疫治疗的临床经验:纳武利尤单抗同情用药项目治疗晚期鳞状非小细胞肺癌患者的疗效和毒性分析。
Oncol Res Treat. 2019;42(5):243-255. doi: 10.1159/000499321. Epub 2019 Apr 17.
5
LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.LAYN 是胃癌和结肠癌的预后生物标志物,并与免疫浸润相关。
Front Immunol. 2019 Jan 29;10:6. doi: 10.3389/fimmu.2019.00006. eCollection 2019.
6
Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: Comparing survival outcomes in adenocarcinoma and squamous cell carcinoma.立体定向消融放疗(SABR)治疗早期非小细胞肺癌:腺癌和鳞癌生存结局比较。
Lung Cancer. 2019 Feb;128:127-133. doi: 10.1016/j.lungcan.2018.12.022. Epub 2018 Dec 24.
7
Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?在联合化疗的情况下,哪种免疫疗法是晚期鳞状非小细胞肺癌的最佳选择:抗 PD-1 还是抗 PD-L1?
J Immunother Cancer. 2018 Dec 3;6(1):135. doi: 10.1186/s40425-018-0427-6.
8
Transcriptomic and functional network features of lung squamous cell carcinoma through integrative analysis of GEO and TCGA data.通过 GEO 和 TCGA 数据的综合分析,揭示肺鳞癌的转录组和功能网络特征。
Sci Rep. 2018 Oct 26;8(1):15834. doi: 10.1038/s41598-018-34160-w.
9
Identification of an eight-gene prognostic signature for lung adenocarcinoma.肺腺癌八基因预后特征的鉴定
Cancer Manag Res. 2018 Sep 10;10:3383-3392. doi: 10.2147/CMAR.S173941. eCollection 2018.
10
Knockdown of POLE2 expression suppresses lung adenocarcinoma cell malignant phenotypes in vitro.POLE2 表达的敲低抑制肺腺癌细胞的体外恶性表型。
Oncol Rep. 2018 Nov;40(5):2477-2486. doi: 10.3892/or.2018.6659. Epub 2018 Aug 17.